ALMS · Alumis Inc
United States · RS rating 18 · As of 2026-11-03
| Price | 6.50 USD |
|---|---|
| 1-day change | +1.9% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 45 / 3 / 79 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 15 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -49.6% |
| Sales growth Q/Q | -6.6% |
| Distance from 52-week high | +78.5% |
| Market cap (USD) | $3.3B |